本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Impact Biomedical, Inc.

0.4580
-0.0120-2.55%
盤後0.4489-0.0091-1.99%18:25 EST
成交量:5.47萬
成交額:2.48萬
市值:4,809.00萬
市盈率:-0.12
高:0.4700
開:0.4474
低:0.4358
收:0.4700
52周最高:6.17
52周最低:0.3621
股本:1.05億
流通股本:1,163.81萬
量比:0.57
換手率:0.47%
股息:- -
股息率:- -
每股收益(TTM):-3.6869
每股收益(LYR):-2.2969
淨資產收益率:-346.99%
總資產收益率:-7.68%
市淨率:-4.05
市盈率(LYR):-0.20

資料載入中...

2024/09/09

SEC問詢函

Form CORRESP - Correspondence
2024/09/05

SEC問詢函

Form CORRESP - Correspondence
2024/09/05

SEC問詢函

Form CORRESP - Correspondence
2024/09/03

SEC問詢函

Form CORRESP - Correspondence
2024/09/03

SEC問詢函

Form CORRESP - Correspondence
2024/08/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/20

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

SEC問詢函

Form CORRESP - Correspondence
2024/08/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

SEC問詢函

Form CORRESP - Correspondence
2024/08/08

SEC問詢函

Form CORRESP - Correspondence
2024/06/11

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/28

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/22

重要事件披露

Form 8-K - Current report
2023/11/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]